1-(4-Benzyloxy-3-methoxyphenyl)ethanone
CAS : 1835-11-6
Ref. 3D-FB18464
1g | Arrêté | ||
2g | Arrêté | ||
5g | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- 1-[3-Methoxy-4-(phenylmethoxy)phenyl]ethanone4'-(Benzyloxy)-3'-methoxy-acetophenoneAcetovanillone benzyl ether
- 1-(3-Methoxy-4-phenylmethoxyphenyl)ethanone
- 1-[3-(Benzyloxy)-4-Methoxyphenyl]Ethanone
- 1-[3-Methoxy-4-(phenylmethoxy)phenyl]ethanone
- 1-[4-(Benzyloxy)-3-Methoxyphenyl]Ethanone
- 1-[4-(Benzyloxy)-3-methoxyphenyl]ethan-1-one
- 3′-Methoxy-4′-(benzyloxy)acetophenone
- Acetophenone, 4′-(benzyloxy)-3′-methoxy-
- Acetovanillone benzyl ether
- Ethanone, 1-[3-methoxy-4-(phenylmethoxy)phenyl]-
- Voir d'autres synonymes
- NSC 201234
- 4′-(Benzyloxy)-3′-methoxyacetophenone
Oxidation products of 1-(4-Benzyloxy-3-methoxyphenyl)ethanone (BMPEA) are found in a variety of food products, including energy drinks. BMPEA is a molecule that has been investigated for clinical development as an anti-inflammatory drug. It is thought to have potential use in the treatment of cancer, obesity, and diabetes. BMPEA binds to tyrosine kinase and factor receptors, which are proteins that regulate cell growth and differentiation. It also interacts with other signaling pathways such as mitogen-activated protein kinases (MAPKs). The linker in this molecule plays a key role in its ability to interact with these proteins by stabilizing the binding sites on their surfaces.
BMPEA has been shown to promote the growth of some types of tumor cells by binding to their surface receptors and stimulating them to grow. However, it also inhibits the growth of other types of tumor cells by competing with epider